School event at the ESGCT 2024 Annual Congress
DNA and cure: A window into the world of advanced therapies
E-Seminar - Coalition of International Gene Therapy Societies- 26 September
When: Thursday 26 September 2024 Australian Eastern Standard Time (AEST): 10.00 PM Central European Summer Time (CEST): 2.00 PM Eastern...
Call for Conference Grants: Apply Now for GenE-Humdi ITC Grants
Supporting the attendance and participation at the upcoming ESGCT Congress for students from ITC and NNC countries.
e-SEMINAR WITH FEDERICA ESPOSITO AND IVANA TRAPANI
Hosted as part of the AROUND THE WORLD SERIES in collaboration with the Coalition of International Gene Therapy Societies.
Momentum in Cell and Gene Therapy Symposium, June 19 in Evry
Please attend our upcoming event, the Momentum in Cell and Gene Therapy Symposium which is co-organized by ART-TG (Inserm) and...
New plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Great Ormond Street Hospital (GOSH), supported by LifeArc and Great Ormond Street Hospital Children’s Charity (GOSH Charity), has...
VIVEbiotech announces significant growth in 2023
San Sebastián, Spain, December 14, 2023 - VIVEbiotech, S.L., a GMP contract development and manufacturing organization (CDMO) full...
FDA Investigating Serious Risk of T-cell Malignancy
FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T...
Nobel Prize in Medicine 2023
The ESGCT would like to congratulate Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that...
VIVEbiotech participates in the European MAGIC project
The MAGIC consortium is committed to making a meaningful impact on the lives of individuals affected by muscular dystrophies.
